Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-10-15
1986-10-14
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544230, 514217, 546 18, 540523, 540543, C07D40110, C07D40310, A61K 3150, A61K 3155
Patent
active
046173021
ABSTRACT:
This invention provides certain pyridazinone derivatives, their pharmaceutical formulations, and their use as positive inotropic agents.
REFERENCES:
patent: 3845050 (1974-10-01), Lebkuecher et al.
patent: 4258185 (1981-03-01), Nakao et al.
patent: 4304777 (1981-12-01), Lesher et al.
patent: 4353905 (1982-10-01), Sircar et al.
patent: 4361563 (1982-11-01), Austel et al.
patent: 4397854 (1983-08-01), Sircar
patent: 4404203 (1983-09-01), Sircar
Curran et al., J. Med. Chem., 17(3), 273 (1974).
McEvoy et al., J. Med. Chem., 17(3), 281 (1974).
Derwent 27593K/12 abstracting German OLS No. 3,135,617.
Derwent 18918K/08 abstracting Japanese Patent No. J58008016.
Nakao Chemical Abstracts 93:46702d (1980).
Aghalyan Chemical Abstracts 91:140700g (1979).
M.T.C., Inc. Chemical Abstracts 101:90957y (1984).
Japanese Abstract of Japan Patent Publication No. 58-8016.
Berch Mark L.
Conrad Robert A.
Eli Lilly and Company
LandOfFree
Inotropic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inotropic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inotropic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1340474